Patents by Inventor Stuart DOWALL

Stuart DOWALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HANTAVIRUS ANTIGENIC COMPOSITION
    Publication number: 20220275346
    Abstract: The present invention provides a viral vector or bacterial vector, said vector comprising a nucleic acid sequence encoding a Hantavirus nucleoprotein or antigenic fragment thereof; wherein said vector is capable of inducing a protective immune response in a subject. The present invention also provides compositions and uses of the vector in methods of medical treatment.
    Type: Application
    Filed: July 29, 2020
    Publication date: September 1, 2022
    Applicant: SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE
    Inventors: Roger Hewson, Stuart Dowall, Emma Kennedy, Miles Carroll
  • Filovirus therapy
    Patent number: 10519219
    Abstract: The present invention provides antibodies, for use in the treatment, suppression prevention of Filovirus disease, particularly Ebola virus disease. Also provided immunogens for use in eliciting such antibodies.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: December 31, 2019
    Assignees: The Secretary of State for Health, MicroPharm Limited, The Chancellor, Masters and Scholars of the University of Oxford
    Inventors: Miles Carroll, Stuart Dowall, Roger Hewson, Ian Cameron, John Landon, Antra Zeltina, David Stuart, Thomas Bowden
  • Crimean-congo haemorrhagic fever virus antigenic composition
    Patent number: 10059747
    Abstract: The present invention provides a viral vector or bacterial vector, said vector comprising a nucleic acid sequence encoding a Crimean-Congo Haemorrhagic Fever Virus (CCHFV) glycoprotein or antigenic fragment thereof; wherein said vector is capable of inducing an immune response in a subject. The present invention also provides compositions and uses of the vector in methods of medical treatment.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: August 28, 2018
    Assignee: THE SECRETARY OF STATE FOR HEALTH
    Inventors: Karen Buttigieg, Mile Carroll, Roger Hewson, Stuart Dowall, Stephen Findlay-Wilson, Aleksandra Miloszewska
  • FILOVIRUS THERAPY
    Publication number: 20180105580
    Abstract: The present invention provides antibodies, for use in the treatment, suppression prevention of Filovirus disease, particularly Ebola virus disease. Also provided immunogens for use in eliciting such antibodies.
    Type: Application
    Filed: February 10, 2016
    Publication date: April 19, 2018
    Applicants: The Secretary of State for Health, MicroPharm Limited, The Chancellor, Masters and Scholars of the University of Oxford
    Inventors: Miles Carroll, Stuart Dowall, Roger Hewson, Ian Cameron, John Landon, Antra Zeltina, David Stuart, Thomas Bowden
  • CRIMEAN-CONGO HAEMORRHAGIC FEVER VIRUS ANTIGENIC COMPOSITION
    Publication number: 20150361141
    Abstract: The present invention provides a viral vector or bacterial vector, said vector comprising a nucleic acid sequence encoding a Crimean-Congo Haemorrhagic Fever Virus (CCHFV) glycoprotein or antigenic fragment thereof; wherein said vector is capable of inducing an immune response in a subject. The present invention also provides compositions and uses of the vector in methods of medical treatment.
    Type: Application
    Filed: November 29, 2013
    Publication date: December 17, 2015
    Inventors: Karen BUTTIGIEG, Mile CARROLL, Roger HEWSON, Stuart DOWALL, Stephen FINDLAY-WILSON, Aleksandra MILOSZEWSKA